Application Note: Fecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study
30 November 2022

In this article, Alpha Laboratories describes a study that was undertaken to determine the diagnostic accuracy of fecal calprotectin in patients referred with suspected colorectal cancer, both for clinically significant colorectal neoplasia and for all organic enteric disease.